NasdaqGS:ALKSBiotechs
Is It Time To Reassess Alkermes (ALKS) After Mixed Share Price Performance?
If you are wondering whether Alkermes at around US$33.16 is offering good value right now, this article will walk through what the numbers actually suggest.
The share price performance shows a mixed picture, with a 5% decline over the last 7 days, a 4.8% gain over the last 30 days, a 17.3% gain year to date, and a 7.6% decline over the last year alongside gains of 20.1% over 3 years and 72.1% over 5 years.
Recent coverage has focused on Alkermes as a long established player in the...